Last edition
News about "Novartis China for Cosentyx"
Novartis secures approval in China for Cosentyx
Novartis has announced that the China National Medical Products Administration (NMPA) has further approved Cosentyx for the treatment of moderate-to-severe plaque psoriasis in paediatric patients
Novartis China For Cosentyx | 19/08/2021 | By Darshana | 399
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members